BioRestorative Therapies vs Ernexa Therapeutics
BRTX and ERNA side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BRTX and ERNA compare
BioRestorative Therapies is the larger company, worth 13 times as much as Ernexa Therapeutics ($39.7M against $3.2M).
BioRestorative Therapies scores higher on the StockData Score (8 against 6 for Ernexa Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BRTX | ERNA |
|---|---|---|
| Size and price | ||
| Market cap | $39.7M | $3.2M |
| Share price | $1.56 | $1.93 |
| Change, 1 year | −94.3% | −95.4% |
| Change, 5 years | −98.9% | −100.0% |
| Beta (5Y) | 1.08 | 1.59 |
| Employees | 14 | 5 |
| StockData Score | ||
| Total score | 8 (better) | 6 |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 (better) | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 111× | – |
| P/B | 13.1× | 0.7× (better) |
| FCF yield | – | −341% |
| Growth | ||
| Revenue growth (TTM) | −8.5% | – |
| Revenue growth, 5Y average | 36.1% | – |
| Profitability | ||
| Gross margin | 92.1% | – |
| Operating margin | −3975% | – |
| Net margin | −3090% | – |
| Return on equity | −241% (better) | −352% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 2.35 | 2.57 (better) |
| Altman Z-score | −46.62 (better) | −56.35 |
| Piotroski F-score | 2 | 3 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 0.52% | – |
| Held by insiders | 9.6% | – |
| Insider net buying, 12 months | – | $2.0M |
| Short interest, % of float | 0.16% | – |
Go deeper
- BRTX stock overview
- BRTX income statement
- BRTX valuation and score
- ERNA stock overview
- ERNA income statement
- ERNA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.